| Identification | |
| Name: | Seratrodast |
| CAS: | 112665-43-7 |
| Molecular Formula: | C22H26O4 |
| Molecular Weight: | 354.44 |
| InChI: | InChI=1/C22H26O4/c1-14-15(2)22(26)20(16(3)21(14)25)18(17-10-6-4-7-11-17)12-8-5-9-13-19(23)24/h4,6-7,10-11,18H,5,8-9,12-13H2,1-3H3,(H,23,24) |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.14 g/cm3 |
| Refractive index: | 1.584 |
| Appearance: | pale orange solid |
| Specification: |
Seratrodast , its cas register number is 112665-43-7. It also can be called (+-)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid ; (+-)-2,4,5-Trimethyl-3,6-dioxo-zeta-phenyl-1,4-cyclohexadiene-1-heptanoic acid ; Benzeneheptanoic acid, zeta-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (+-)- .It is a pale orange solid. |
| Biological Activity: | Thromboxane A 2 (TP) receptor antagonist. Antiasthmatic agent; inhibits platelet aggregation and bronchoconstriction induced by a TXA 2 mimetic in guinea pigs. |
| Usage: | Thromboxane A2-receptor antagonist. Antiasthmatic |
| Safety Data | |
 |
|
